INSMED INC Operating Lease, Weighted Average Discount Rate, Percent
INSMED INC (INSM) had Operating Lease, Weighted Average Discount Rate, Percent of 8.90% as of 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-02-19
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 8.90%.
- 2024-12-31: Operating Lease, Weighted Average Discount Rate, Percent 9.00%.
- 2023-12-31: Operating Lease, Weighted Average Discount Rate, Percent 7.60%.
- 2022-12-31: Operating Lease, Weighted Average Discount Rate, Percent 7.00%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2025-12-31 | 8.90% 10-K · filed 2026-02-19 |
| 2024-12-31 | 9.00% 10-K · filed 2026-02-19 |
| 2023-12-31 | 7.60% 10-K · filed 2025-02-20 |
| 2022-12-31 | 7.00% 10-K · filed 2024-02-22 |
| 2021-12-31 | 7.00% 10-K · filed 2023-02-23 |
| 2020-12-31 | 7.40% 10-K · filed 2022-02-17 |
| 2020-09-30 | 7.40% 10-Q · filed 2020-10-29 |
| 2020-06-30 | 7.40% 10-Q · filed 2020-08-06 |
| 2020-03-31 | 7.40% 10-Q · filed 2020-04-30 |
| 2019-12-31 | 7.40% 10-K · filed 2021-02-25 |
| 2019-09-30 | 7.40% 10-Q · filed 2019-10-30 |
| 2019-06-30 | 7.30% 10-Q · filed 2019-08-01 |
| 2019-03-31 | 7.30% 10-Q · filed 2019-05-07 |
| 2018-09-30 | 7.40% 10-Q · filed 2019-10-30 |
| 2018-06-30 | 7.30% 10-Q · filed 2019-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |